Search by Drug Name or NDC

    NDC 69230-0321-33 Levocetirizine Dihydrochloride 5 mg/1 Details

    Levocetirizine Dihydrochloride 5 mg/1

    Levocetirizine Dihydrochloride is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Camber Consumer Care Inc. The primary component is LEVOCETIRIZINE DIHYDROCHLORIDE.

    Product Information

    NDC 69230-0321
    Product ID 69230-321_7ca0cee0-b628-4266-b361-ad5c52b6f11e
    Associated GPIs 41550027100320
    GCN Sequence Number 048920
    GCN Sequence Number Description levocetirizine dihydrochloride TABLET 5 MG ORAL
    HIC3 Z2Q
    HIC3 Description ANTIHISTAMINES - 2ND GENERATION
    GCN 14901
    HICL Sequence Number 022959
    HICL Sequence Number Description LEVOCETIRIZINE DIHYDROCHLORIDE
    Brand/Generic Generic
    Proprietary Name Levocetirizine Dihydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Levocetirizine Dihydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name LEVOCETIRIZINE DIHYDROCHLORIDE
    Labeler Name Camber Consumer Care Inc
    Pharmaceutical Class Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA213513
    Listing Certified Through 2024-12-31

    Package

    NDC 69230-0321-33 (69230032133)

    NDC Package Code 69230-321-33
    Billing NDC 69230032133
    Package 1 BOTTLE in 1 CARTON (69230-321-33) / 80 TABLET, FILM COATED in 1 BOTTLE
    Marketing Start Date 2020-10-28
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.17703
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description LEVOCETIRIZINE 5 MG TABLET
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL be72dafb-62ae-40b2-874f-1d8920fad19d Details

    Revised: 11/2020